TMPRSS4 and non-small cell lung carcinoma: Significant hypomethylation (p < 0.01) was found for TMPRSS4 in the case of patients with early stage (I–II) NSCLC in comparison with controls (Figure 4A), with an AUROC of 0.72 ((95% CI, 0.57–0.87), p = 0.008) (Figure 4B).